Index of reports
> Cases with Myelodysplastic Syndrome (11)
Below is the selection of side effect reports (a.k.a. adverse event reports) related to Alkeran (Melphalan) where reactions include myelodysplastic syndrome. The selected reports were submitted to the FDA during the sample period of about a year.
Possible Alkeran side effects in 60 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-09
Patient: 60 year old female
Reactions: Myelofibrosis, Acute Myeloid Leukaemia, Myelodysplastic Syndrome, Idiopathic Thrombocytopenic Purpura
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Bicnu
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Cyclophosphamide
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Dexamethasone
Dosage: 4 years, intravenous (not otherwise specified)
Indication: Multiple Myeloma
Doxorubicin Hydrochloride
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Prednisone
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Velcade
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Start date: 2008-05-05
Velcade
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Start date: 2008-05-19
Velcade
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Start date: 2008-04-08
Vepesid
Dosage: intravenous (not otherwise sepcified)
Indication: Multiple Myeloma
Vincristine Sulfate
Dosage: intravenous (not otherwise specified)
Indication: Multiple Myeloma
Other drugs received by patient: Neupogen; Corticosteroids
Possible Alkeran side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Bicnu
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Dexamethasone
Start date: 2008-04-08
Dexamethasone
Start date: 2008-06-01
End date: 2008-01-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2008-05-05
Dexamethasone
Start date: 2008-05-19
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Prednisone
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2008-04-08
End date: 2008-09-01
Vepesid
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Vincristine
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Possible Alkeran side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2012-08-01
Patient: female
Reactions: Acute Myeloid Leukaemia, Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Bicnu
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Cyclophosphamide
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Dexamethasone
Indication: Multiple Myeloma
Start date: 2004-01-01
End date: 2008-01-01
Dexamethasone
Start date: 2008-04-08
End date: 2008-09-01
Doxorubicin Hydrochloride
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Prednisone
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2008-04-08
End date: 2008-06-01
Vepesid
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Vincristine
Indication: Multiple Myeloma
Start date: 2000-01-01
End date: 2000-01-01
Possible Alkeran side effects in female
Reported by a health professional (non-physician/pharmacist) from United States on 2012-03-01
Patient: female
Reactions: Myelodysplastic Syndrome, Multiple Myeloma
Adverse event resulted in: death
Drug(s) suspected as cause:
Alkeran
Indication: Multiple Myeloma
Bortezomib
Indication: Multiple Myeloma
Cisplatin
Indication: Multiple Myeloma
Cyclophosphamide
Indication: Multiple Myeloma
Dexamethasone
Indication: Multiple Myeloma
Doxorubicin HCL
Indication: Multiple Myeloma
Etoposide
Indication: Multiple Myeloma
Lenalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-04-09
End date: 2008-01-29
Thalomid
Administration route: Oral
Indication: Multiple Myeloma
Vincristine
Indication: Multiple Myeloma
Possible Alkeran side effects in female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-07
Patient: female
Reactions: Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Dosage: 16 milligram
Administration route: Oral
Start date: 2007-10-01
End date: 2008-01-01
Alkeran
Dosage: 200 mg/m2 depending on cycle
Administration route: Oral
Start date: 2003-10-01
End date: 2003-10-01
Cyclophosphamide
Dosage: 4ug/m2 depending on cylce
Start date: 2003-05-27
End date: 2003-05-27
Dexamethasone
Administration route: Oral
Start date: 2003-02-01
End date: 2003-08-01
Dexamethasone
Dosage: depending on cycle
Administration route: Oral
Start date: 2009-12-12
End date: 2010-10-01
Doxorubicin HCL
Start date: 2003-02-01
End date: 2003-01-01
Granocyte
Dosage: 800 ug, depending on cycle
Start date: 2011-06-12
End date: 2011-06-18
Mozobil
Dosage: depending on cycle
Start date: 2011-06-13
End date: 2011-06-16
Prednisolone
Dosage: 170 milligram
Administration route: Oral
Start date: 2007-10-01
End date: 2008-01-01
Revlimid
Dosage: 25 milligram
Administration route: Oral
Start date: 2009-12-12
End date: 2010-10-01
Velcade
Dosage: depending on cycle
Start date: 2007-10-01
End date: 2008-01-01
Vincristine
Start date: 2003-02-01
End date: 2003-08-01
Possible Alkeran side effects in 59 year old female
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-06
Patient: 59 year old female
Reactions: Myelodysplastic Syndrome
Adverse event resulted in: life threatening event
Drug(s) suspected as cause:
Alkeran
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-10-01
End date: 2008-01-01
Alkeran
Administration route: Oral
Start date: 2003-10-01
End date: 2003-10-01
Cyclophosphamide
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2003-05-27
End date: 2003-05-27
Dexamethasone
Administration route: Oral
Start date: 2003-02-01
End date: 2003-08-01
Dexamethasone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-12-12
End date: 2010-10-01
Doxorubicin HCL
Indication: Multiple Myeloma
Start date: 2003-02-01
End date: 2003-08-01
Lenalidomide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-12-12
End date: 2010-10-01
Lenograstim
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-06-12
End date: 2011-06-18
Plerixafor
Indication: Haematopoietic Stem Cell Mobilisation
Start date: 2011-06-13
End date: 2011-06-16
Prednisolone
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-10-01
End date: 2008-01-01
Velcade
Indication: Multiple Myeloma
Start date: 2007-10-01
End date: 2008-01-01
Vincristine Sulfate
Indication: Multiple Myeloma
Start date: 2003-02-01
End date: 2003-08-01
Possible Alkeran side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-12-05
Patient: 58 year old male
Reactions: Myelodysplastic Syndrome
Drug(s) suspected as cause:
Alkeran
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-06-05
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-01-01
Doxorubicin HCL
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-09-27
Etoposide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-08-28
Velcade
Indication: Multiple Myeloma
Start date: 2007-05-04
End date: 2007-09-27
Other drugs received by patient: Dexamethasone
Possible Alkeran side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-11-30
Patient: 58 year old male
Reactions: Myeloma Recurrence, Neoplasm Malignant, Myelodysplastic Syndrome, Transplant, Herpes Zoster
Drug(s) suspected as cause:
Alkeran
Dosage: 125 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-06-05
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-09-27
Etoposide
Dosage: unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-08-28
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2007-05-04
End date: 2007-07-10
Velcade
Dosage: unk
Start date: 2007-07-31
End date: 2007-09-27
Possible Alkeran side effects in 85 year old male
Reported by a health professional (non-physician/pharmacist) from United States on 2011-11-23
Patient: 85 year old male
Reactions: Myelodysplastic Syndrome, Multiple Myeloma
Drug(s) suspected as cause:
Alkeran
Revlimid
Dosage: 25mg per day
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2009-02-01
End date: 2009-01-01
Other drugs received by patient: Velcade; Prednisone TAB
Possible Alkeran side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-25
Patient: 58 year old male
Reactions: Myelodysplastic Syndrome
Drug(s) suspected as cause:
Alkeran
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-06-05
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-01-01
Doxorubicin HCL
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-09-27
Etoposide
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-08-28
Velcade
Indication: Multiple Myeloma
Start date: 2007-05-04
End date: 2007-09-27
Other drugs received by patient: Dexamethasone
Possible Alkeran side effects in 58 year old male
Reported by a health professional (non-physician/pharmacist) from France on 2011-10-24
Patient: 58 year old male
Reactions: Neoplasm Malignant, Myelodysplastic Syndrome
Drug(s) suspected as cause:
Alkeran
Dosage: 125 mg, unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-06-05
Cyclophosphamide
Administration route: Oral
Indication: Multiple Myeloma
Doxorubicin HCL
Dosage: unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-09-27
Etoposide
Dosage: unk
Administration route: Oral
Indication: Multiple Myeloma
Start date: 2007-08-28
Velcade
Dosage: unk
Indication: Multiple Myeloma
Start date: 2007-05-04
End date: 2007-07-10
Velcade
Dosage: unk
Start date: 2007-07-31
End date: 2007-09-27
|